CARTEOLOL vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARTEOLOL vs CASIRIVIMAB\IMDEVIMAB: Safety Overview
| Metric | CARTEOLOL | CASIRIVIMAB\IMDEVIMAB |
|---|---|---|
| Total FAERS Reports | 318 | 4,248 |
| Deaths Reported | 30 | 137 |
| Death Rate | 9.4% | 3.2% |
| Hospitalizations | 93 | 1,351 |
| Average Patient Age | 67.5 yrs | 54.3 yrs |
| % Female Patients | 56.6% | 55.4% |
| FDA Approval Date | Dec 28, 1988 | N/A |
| Manufacturer | Sandoz Inc | N/A |
| Route | OPHTHALMIC | N/A |
| Marketing Status | Discontinued | N/A |